Aleksandr V Yurkovetskiy

Discovery of Novel Polyamide-Pyrrolobenzodiazepine Hybrids for Antibody-Drug Conjugates.

N. Bodyak, D. Gumerov, Liuliang Qin, 2022, Bioorganic & medicinal chemistry letters.

Dolaflexin: A Novel Antibody–Drug Conjugate Platform Featuring High Drug Loading and a Controlled Bystander Effect

D. Bergstrom, M. Protopopova, N. Bodyak, 2021, Molecular Cancer Therapeutics.

The Dolaflexin-based Antibody–Drug Conjugate XMT-1536 Targets the Solid Tumor Lineage Antigen SLC34A2/NaPi2b

D. Bergstrom, M. Protopopova, N. Bodyak, 2021, Molecular Cancer Therapeutics.

Process Development and GMP Production of a Conjugate Warhead: Auristatin F-HPA-Ala/TFA (XMT-1864/TFA)

T. Wagler, Zhongmin Xu, M. Kaufman, 2022, Organic Process Research & Development.

Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody–Drug Conjugate for the Treatment of Cancer

Jeremy R. Duvall, S. Collins, Phonphimon Wongthida, 2023, Molecular cancer therapeutics.